Naloxone: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - " pt " to " patient ") |
ClaireLewis (talk | contribs) |
||
| Line 18: | Line 18: | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | ||
*Lactation: | *Lactation: insufficient data | ||
*Renal Dosing | *Renal Dosing | ||
**Adult | **Adult | ||
Revision as of 21:10, 12 July 2016
General
- Type: Opioid antagonists
- Dosage Forms:
- Common Trade Names: Narcan
Adult Dosing
Opioid toxicity
- Bolus (May repeat q3min up to max dose 10mg
- Apneic or near-apneic - 2mg IV
- Opioid-naive with minimal respiratory depression - 0.4mg IV
- Opioid-dependent with minimal respiratory depression - 0.05mg IV
- Infusion
- Only give if the patient responded to the bolus and required repeat administration
- Step 1: Determine the "wake-up dose" or bolus required to wake the pt
- Step 2: Give 2/3 of the "wake-up dose" per hr; mix in 1L D5W
Pediatric Dosing
Special Populations
- Pregnancy Rating: C
- Lactation: insufficient data
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
- Opioid withdrawal
- Serious complications are rare
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Onset of action - 1-2min
- Duration of action - 20-90min (may be less than that of the ingested opioid)